Leukotriene biosynthesis inhibition ameliorates acute lung injury following hemorrhagic shock in rats

Journal of Cardiothoracic Surgery

Volumn 6, Issue 1, 2011, Pages

  Al Amran, Fadhil G ^a   Hadi, Najah R ^b   Hashim, Ali M ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF KUFA   (Iraq)

Author keywords

Inflammatory markers; MK 886hemorrhagic shockacute lung injuryoxidative stress

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; INDOLE DERIVATIVE; LEUKOTRIENE B4; LEUKOTRIENE C4; LIPOXYGENASE INHIBITOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA;

ACUTE LUNG INJURY; ANIMAL; ARTICLE; BIOSYNTHESIS; COMPARATIVE STUDY; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; HEMORRHAGIC SHOCK; MALE; METABOLISM; OXIDATIVE STRESS; RAT; TREATMENT OUTCOME;

ACUTE LUNG INJURY; ANIMALS; DISEASE MODELS, ANIMAL; INDOLES; LEUKOTRIENE B4; LEUKOTRIENE C4; LIPOXYGENASE INHIBITORS; MALE; OXIDATIVE STRESS; PPAR ALPHA; RATS; SHOCK, HEMORRHAGIC; TREATMENT OUTCOME;

EID: 79957950389     PISSN: None     EISSN: 17498090     Source Type: Journal    
DOI: 10.1186/1749-8090-6-81     Document Type: Article

References (63)

1. Bhatia M, Moochhala S. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol 2004, 202:145-56. 10.1002/path.1491, 14743496.
2. Jarrar D, Chaudry IH, Wang P. Organ dysfunction following hemorrhage and sepsis: mechanisms and therapeutic approaches. Int J Mol Med 1999, 4:575-583.
3. Hudson LD, Milberg JA, Anardi D, Maunder RJ. Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1995, 151:293-301.
4. Keel M, Trentz O. Pathophysiology of polytrauma. Injury 2005, 36:691-709. 10.1016/j.injury.2004.12.037, 15910820.
5. Anaya-Prado R, Toledo-Pereyra LH, Lentsch AB, Ward PA. Ischemia/reperfusion injury. J Surg Res 2002, 105:248-258. 10.1006/jsre.2002.6385, 12125704.
6. Rizoli SB, Kapus A, Fan J, Li YH, Marshall JC, Rotstein OD. Immunomodulatory effects of hypertonic resuscitation on the development of lung inflammation following hemorrhagic shock. J Immunol 1998, 161:6288-6296.
7. Yu HP, Shimizu T, Hsieh YC, Suzuki T, Choudhry MA, Schwacha MG, et al. Tissue specific expression and their role in the regulation of neutrophil infiltration in various organs following trauma-hemorrhage. J Leukoc Biol 2006, 79:963-970. 10.1189/jlb.1005596, 16478916.
8. Yu HP, Hsieh YC, Suzuki T, Shimizu T, Choudhry MA, Schwacha MG, et al. Salutary effects of estrogen receptor-β agonist on lung injury after trauma-hemorrhage. Am J Physiol Lung Cell Mol Physiol 2006, 290:L1004-L1009. 10.1152/ajplung.00504.2005, 16361351.
9. Gillard J, Ford-Hutchinson AW, Chan C, Charleson S, Denis D, Foster A, et al. Full-size imageL-663,536 (MK-886) (3-1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl) 2,2-dimethylpro-panoic acid), a novel, orally active leukotriene biosynthesis inhibitor. Can J Physiol Pharmacol 1989, 67(5):456-464. 10.1139/y89-073, 2548691.
10. Dixon RAF, Diehl RE, Opas E, Rands E, Vickers PJ, Evans JF, et al. Requirement of a 5-lipoxygenase activating protein for leukotriene synthesis. Nature 1990, 343:282-284. 10.1038/343282a0, 2300173.
11. Rouzer CA, Ford-Hutchinson AW, Morton HE, Gillard JW. MK-886, a potent and specific leukotriene biosynthesis inhibitor, blocks and reverses the membrane association of 5-lipooxygenase in ionophore challenged leucocytes. J Biol Chem 1990, 265:1436-1442.
12. Guidot DM, Repine MJ, Westcott JY, Repine JE. Intrinsic 5-lipoxygenase activity is required for neutrophil responsivity. Proc Natl Acad Sci USA 1994, 91:8156-8159. 10.1073/pnas.91.17.8156, 44564, 8058773.
13. Fernandez-gallardo S, Gijon MA, Garcia C, Furio V, Ciu FT, Crespo SM. The role of platelet activating factor and peptidoleukotrienes in the vascular changes of rat passive anaphylaxis. Br J Pharmacol 1992, 105:119-125. 1908595, 1596674.
14. Lehr HA, Guhlmann A, Nolte D, Keppler D, Messmers K. Leukotrienes as mediators in ischemia-reperfusion injury in a microcirculation model in the hamster. J Clin Invest 1991, 87:2036. 10.1172/JCI115233, 296959, 1645749.
15. Daglar G, Karaca T, Yuksek YN, Gozalan U, Akbiyik F, Sokmensuer C, et al. Effect of Montelukast and MK-886 on Hepatic Ischemia-Reperfusion Injury in Rats. Journal of surgical research 2009, 153(1):31-38. 10.1016/j.jss.2008.02.052, 18656901.
16. Wallace JL, Keenan CM. An orally active inhibitor of leukotriene synthesis accelerates healing in rat model of colitis. Am J Physiol 1990, 258:G527-G534.
17. Eun JC, Moore EE, Mauchley DC, Meng X, Banerjee A. The 5-Lipoxygenase Pathway Meditates Acute Lung Injury Following Hemorrhagic Shock. Journal of Surgical Research 2010, 158(2):215-216.
18. Kilicoglu B, Eroglu E, Kilicoglu SS, Kismet K, Eroglu F. Effect of abdominal trauma on hemorrhagic shock induced acute lung injury in rats. World J Gastroenterol 2006, 12(22):3593-3596.
19. Rhee P, Waxman K, Clark L, Kaupke CJ, Vaziri ND, Tominaga G, et al. Tumor necrosis factor and monocytes are released during hemorrhagic shock. Resuscitation 1993, 25(3):249-255. 10.1016/0300-9572(93)90122-7, 8351422.
20. Yu HP, Hsieh PW, Chang YJ, Chung PJ, Kuo LM, Hwang TL. DSM-RX78, a new phosphodiesterase inhibitor, suppresses superoxide anion production in activated human neutrophils and attenuates hemorrhagic shock-induced lung injury in rats. Biochemical pharmacology 2009, 78(8):983-992. 10.1016/j.bcp.2009.06.008, 19540209.
21. Josephson B, Gyllenswärd C. Scand J Clin Lab Invest 1957, 9:29. 10.3109/00365515709088110, 13432630.
22. Beuge JA, Aust SD. Microsomal lipid peroxidation. Meth Enzymol 1978, 52:302-311.
23. Matute-Bello G, Winn RK, Jonas M, Chi EY, Martin TR, Liles WC. Fas (CD95) induces alveolar epithelial cell apoptosis in vivo: Implications for acute pulmonary inflammation. Am J Pathol 2001, 158:153. 10.1016/S0002-9440(10)63953-3, 1850249, 11141488.
24. Souza DG, Coutinho SF, Silveira MR, Cara DC, Teixeira MM. Effects of a BLT receptor antagonist on local and remote reperfusion injuries after transient ischemia of the superior mesenteric artery in rats. Eur J Pharmacol 2000, 403:121. 10.1016/S0014-2999(00)00574-4, 10969152.
25. Noiri E, Yokomizo T, Nakao A, Izumi T, Fujita T, Kimura S, Shimizu T. An in vivo approach showing the chemotactic activity of leukotriene B (4) in acute renal ischemic-reperfusion injury. Proc Natl Acad Sci USA 2000, 97:823. 10.1073/pnas.97.2.823, 15415, 10639164.
26. Rossoni G, Sala A, Berti F, Testa T, Buccellati C, Molta C, et al. Myocardial protection by the leukotriene synthesis inhibitor BAY X1005: Importance of transcellular biosynthesis of cysteinyl-leukotrienes. J Pharmacol Exp Ther 1996, 276:335.
27. Takamatsu Y, Shimada K, Chijiiwa K, Kuroki S, Yamaguchi K, Tanaka M. Role of leukotrienes on hepatic ischemia/reperfusion injury in rats. Journal of Surgical Research 2004, 119(1):14-20. 10.1016/j.jss.2003.07.004, 15126076.
28. Eun JC, Moore EE, Jordan JR, Peltz ED, Banerjee A. Products of the 5-lipoxygenase pathway are critical for the development of acute lung injury following hemorrhagic shock. Journal Of the American College of Surgeons 2009, 209(3):S35. Suppl 1.
29. Eun JC, Moore EE, Mauchley DC, Meng X, Banerjee A. The 5-Lipoxygenase Pathway Meditates Acute Lung Injury Following Hemorrhagic Shock. Journal of Surgical Research 2010, 158(2):215-216.
30. Jordan JR, Moore EE, Damle SS, Kashuk SB, Silliman CC, et al. Arachidonic acid in postshock mesenteric lymph induces pulmonary synthesis of leukotriene B4. J Appl Physiol 2008, 104:1161-1166. 10.1152/japplphysiol.00022.2007, 18276905.
31. Amat M, Barcons M, Mancebo J, Mateo J, Oliver A, Mayoral JF, et al. Evolution of leukotriene B4, peptide leukotrienes, and interleukin-8 plasma concentrations in patients at risk of acute respiratory distress syndrome and with acute respiratory distress syndrome: mortality prognostic study. Crit Care Med 2000, 28:262-263. 10.1097/00003246-200001000-00051, 10667541.
32. Matthay MA, Eschenbacher WL, Goetzl EJ. Elevated concentrations of leukotriene D4 in pulmonary edema fluid of patients with the adult respiratory distress syndrome. J Clin Immunol 1984, 4:479-483. 10.1007/BF00916578, 6511865.
33. Partrick D, Moore EE, Moore FA, Barnett CC, Silliman CC. Lipid mediators up-regulate cd11b and prime for concordant superoxide and elastase release in human neutrophils. J Trauma 1997, 43:297-303. 10.1097/00005373-199708000-00015, 9291376.
34. Surette ME, Krump E, Picard S, Borgeat P. Activation of leukotriene synthesis in human neutrophils by exogenous arachidonic acid: inhibition by adenosine A2a receptor agonists and crucial role of autocrine activation by leukotriene B4. Mol Pharmacol 1999, 56:1055-1062.
35. Murphy RC, Gijon MA. Biosynthesis and metabolism of leukotrienes. Biochem J 2007, 405:379-395. 10.1042/BJ20070289, 17623009.
36. Guidot DM, Repine MJ, Westcott JY, Repine JE. Intrinsic 5-lipoxygenase activity is required for neutrophil responsivity. Proc Natl Acad Sci USA 1994, 91:8156-8159. 10.1073/pnas.91.17.8156, 44564, 8058773.
37. Fan J, Marshall JC, Jimenez M, Shek PN, Zagorski J, Rotstein OD. Hemorrhagic shock primes for increased expression of cytokine-induced neutrophil chemoattractant in the lung: role in pulmonary inflammation following lipopolysaccharide. J Immunol 1998, 161(1):440-447.
38. Menard L, Pilote S, Naccache PH, Laviolette M, Borgeat P. Inhibitory effects of MK-886 on arachidonic acid metabolism in human phagocytes. Br J Pharmacol 1990, 100:15-20. 1917464, 2164857.
39. Ayala A, Wang P, Ba ZF, Perrin MM, Ertel W, Chaudry IH. Differential alterations in plasma IL-6 and TNF levels after trauma and hemorrhage. Am J Physiol 1991, 260:R167-R171.
40. Vincenzi R, Cepeda LA, Pirani WM, Sannomyia P, Rocha-e-Silva M, Cruz RJ. Small volume resuscitation with 3% hypertonic saline solution decrease inflammatory response and attenuates end organ damage after controlled hemorrhagic shock. The American Journal of Surgery 2009, 198(3):407-414.
41. Mellor EA, Austen KF, Boyce JA. Cysteinyl leukotrienes and uridine diphosphate induce cytokine generation by human mast cells through an interleukin 4-regulated pathway that is inhibited by leukotriene receptor antagonists. J Exp Med 2002, 195:583. 10.1084/jem.20020044, 2193768, 11877481.
42. Oliveira SH, Hogaboam CM, Berlin A, Lukacs NW. SCF-induced airway hyperreactivity is dependent on leukotriene production. Am J Physiol Lung Cell Mol Physiol 2001, 280:L1242-1249.
43. Rola-Pleszczynski M, Stankova J. Leukotriene B4 enhances interleukin-6 (IL-6) production and IL-6 messenger RNA accumulation in human monocytes in vitro: transcriptional and posttranscriptional mechanisms. Blood 1992, 80:1004-1011.
44. Brach MA, de Vos S, Arnold C, Gruss HJ, Mertelsmann R, Herrmann F. Leukotriene B4 transcriptionally activates interleukin-6 expression involving NK-κB and NF-IL6. Eur J Immunol 1992, 22:2705-2711. 10.1002/eji.1830221034, 1327803.
45. Ben-Efraim B, Bonta IL. Modulation of antitumour activity of macrophages by regulation of eicosanoids and cytokine production. Int J Immunopharmacol 1994, 16:397-399. 10.1016/0192-0561(94)90027-2, 7927985.
46. Szabo C. The pathophysiological role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury. Shock 1996, 6:79-88. 10.1097/00024382-199608000-00001, 8856840.
47. Johnson KJ, Fantone JC, Kaplan J, Ward PA. In vivo damage of rat lungs by oxygen metabolites. J Clin Invest 1981, 67:983-993. 10.1172/JCI110149, 370656, 6894154.
48. Lum H, Roebuck KA. Oxidant stress and endothelial dysfunction. Am J Physiol Cell Physiol 2001, 280:C719-C741.
49. Pugin J, Verghese G, Widmer M-C, Matthay MA. The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome. Crit Care Med 1999, 27:304-312. 10.1097/00003246-199902000-00036, 10075054.
50. Magnotti LJ, Upperman JS, Xu DZ, Lu Deitch EA Q. Gut-derived mesenteric lymph but not portal blood increases endothelial cell permeability and promotes lung injury after hemorrhagic shock. Ann Surg 1998, 228:518-527. 10.1097/00000658-199810000-00008, 1191527, 9790341.
51. Deitch EA, Adams C, Lu Q, Xu DZ. A time course study of the protective effect of mesenteric lymph duct ligation on hemorrhagic shock-induced pulmonary injury and the toxic effects of shocked rats on endothelial cell monolayer permeability. Surgery 2001, 129:39-47. 10.1067/msy.2001.109119, 11150032.
52. Funk CD. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 2001, 294:1871-1875. 10.1126/science.294.5548.1871, 11729303.
53. Dahlén SE. Treatment of asthma with antileukotrienes: first line or last resort therapy?. Eur J Pharmacol 2006, 533:40-56. 10.1016/j.ejphar.2005.12.070, 16510137.
54. Ogawa Y, Calhoun WJ. The role of leukotrienes in airway inflammation. J Allergy Clin Immunol 2006, 118:789-798. 10.1016/j.jaci.2006.08.009, 17030228.
55. Crooks SW, Stockley RA. Leukotriene B4. Int J Biochem Cell Biol 1998, 30(2):173-178. 10.1016/S1357-2725(97)00123-4, 9608670.
56. Schmid-Schonbein GW. Capillary plugging by granulocytes and the no-reflow phenomenon in the microcirculation. Fed Proc 1987, 46:2397-2401.
57. Dayal SD, Haskó G, Lu Q, Xu DZ, Caruso JM, Sambol JT, et al. Trauma/Hemorrhagic Shock Mesenteric Lymph Upregulates Adhesion Molecule Expression and IL-6 Production in Human Umbilical Vein Endothelial Cells. Shock 2002, 17(6):491-495. 10.1097/00024382-200206000-00009, 12069186.
58. Ali MH, Schlidt SA, Chandel NS, Hynes KL, Schumacker PT, Gewertz BL. Endothelial permeability and IL-6 production during hypoxia: role of ROS in signal transduction. Am J Physiol 1999, 277:L1057-L1065.
59. Vanita G, Asheesh G, Shalini S, Harish MD, Grover SK, Ratan K. Anti-stress and adaptogenic activity of L-arginine supplementation. eCAM 2005, 2:93-97. 1062147, 15841283.
60. Hoshikawa Y, Sadafumi O, Satoshi S, Tatsuo T, Masayuki C, Chun S, et al. Generation of oxidative stress contributes to the development of pulmonary hypertension induced by hypoxia. J Appl Physiol 2001, 90:1299-1306.
61. Herget J, Wilhelm J, Novotna J, Eckhardt A, Vytasek R, Mrazkova L, et al. A possible role of the oxidant tissue injury in the development of hypoxic pulmonary hypertension. Physiol Res 2000, 49:493-501.
62. Ciceri P, Rabuffetti M, Monopoli A, Nicosia S. Production of leukotrienes in a model of focal cerebral ischemia in the rat. Br J Pharmacol 2001, 133:1323. 10.1038/sj.bjp.0704189, 1621141, 11498518.
63. Farias S, Frey LC, Murphy RC, Heidenreich KA. Injury-Related Production of Cysteinyl Leukotrienes Contributes to Brain Damage following Experimental Traumatic Brain Injury. Journal of Neurotrauma 2009, 26(11):1977-1986. 10.1089/neu.2009.0877, 2822801, 19886806.